ABO-incompatible kidney transplantation

Transplantation Reviews

Volumn 27, Issue 1, 2013, Pages 1-8

  Takahashi, Kota ^a   Saito, Kazuhide ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; BLOOD GROUP A ANTIBODY; BLOOD GROUP ANTIGEN; BLOOD GROUP B ANTIBODY; CARBOHYDRATE ANTIGEN; COMPLEMENT COMPONENT C4D; ERYTHROCYTE ANTIGEN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLASMA PROTEIN; RITUXIMAB;

ACUTE ANTIBODY MEDIATED REJECTION; ACUTE GRAFT REJECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; B LYMPHOCYTE; BIOLOGY; BLEEDING TENDENCY; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL ASSESSMENT; DESENSITIZATION; ENDOTHELIUM CELL; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HUMORAL IMMUNITY; HYPERACUTE GRAFT REJECTION; IMMUNOLOGY; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; JAPAN; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; OPPORTUNISTIC INFECTION; OUTCOME ASSESSMENT; PREOPERATIVE TREATMENT; PROTEIN DEPLETION; PROTEOMICS; REVIEW; SENSITIZATION; SEPSIS; SPLENECTOMY; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

EID: 84873569971     PISSN: 0955470X     EISSN: 15579816     Source Type: Journal    
DOI: 10.1016/j.trre.2012.07.003     Document Type: Review

References (48)

1. Takahashi K., Tanabe K., Ooba S., et al. Prophylactic use of a new immunosuppressive agent deoxyspergualin in patients with kidney transplantation from ABO-incompatible or preformed antibody positive donors. Transplant Proc 1991, 26:1078.
2. Tanabe K., Takahashi K., Ota K., et al. Long term results of ABO-incompatible living kidney transplantation. Transplantation 1998, 65:224.
3. Takahashi K., Saito K., Tanabe K., et al. First report of a seven-year survey on ABO-incompatible kidney transplantation in Japan. Clin Exp Nephrol 2001, 5:119. Multicenter cooperative study group.
4. Takahashi K. ABO-incompatible kidney transplantation 2001, Amsterdam, Elsevier.
5. Takahashi K., Saito K., Takahara S., The Japanese ABO-incompatible Kidney Transplantation Committee, et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004, 4:1089.
6. Takahashi K., Saito K. Present status of ABO-incompatible kidney transplantation in Japan. Xenotransplantation 2006, 13:118. the Japanese ABO-incompatible Kidney Transplantation Committee.
7. Takahashi K. ABO-incompatible kidney transplantation-Establishing a scientific framework 2001, Amsterdam, Elsevier.
8. Alexandre G.P.J., Bruyere M.D.E., Squifflet J.P., et al. Human ABO incompatible living donor renal homografts. Neth J Med 1985, 28:231.
9. Alexandre G.P.J., Squifflet J.P., Bruyere M.D.E., et al. ABO incompatible related and unrelated living donor renal allografts. Transplant Proc 1986, 18:452.
10. Alexandre G.P.J., Latinne D., Gianello P., et al. Preformed cytotoxic antibodies and ABO-incompatible grafts. Clin Transplant 1991, 5:583.
11. Tagareli A. Karl Landsteiner: a hundred year later. Transplantation 2001, 72:3.
12. Takahashi K. Accommodation in ABO-incompatible kidney transplantation: why do kidney grafts survive?. Transplant Proc 2004, (Suppl. 2S):193.
13. Takahashi K. Accommodation in ABO-incompatible kidney transplantation 2004, Amsterdam, Elsevier.
14. Takahashi K. A new concept of accommodation in ABO-incompatible kidney transplantation. Clin Transplant 2005, 19(Suppl.14):76.
15. Takahashi K. Recent findings in ABO-incompatible kidney transplantation: classification and therapeutic strategy for acute antibody-mediated rejection due to ABO-blood-group-related antigens during the critical period preceding the establishment of accommodation. Clin Exp Nephrol 2007, 11:1281.
16. Tasaki M., Yoshida Y., Takahashi K., et al. Identification and characterization of major proteins carrying ABO blood group antigens in the human kidney transplantation. Transplantation 2009, 87:1125.
17. Takahashi K., Imai N., Saito K., et al. Mechanism of acute antibody-mediated rejection in ABO-incompatible kidney transplantation: which anti-A/anti-B antibodies are responsible, natural or de novo?. Transplantation 2010, 89:635. [Letter to the editors].
18. Takahashi K. ABO-incompatible kidney transplantation-why is hyperacute rejection absent? 2011, Elsevier, Amsterdam.
19. Saito K., Takahashi K. The Japan ABO-incompatible transplantation Committee. Current status of ABO-incompatible kidney transplantation in Japan, 2011: results of a questionnaire-based survey. Transplantation Now 2011, 24:589-600.
20. Saito K., Nakagawa Y., Takahashi K., et al. Pinpoint targeted immunosuppression; Anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy. Xenotransplantation 2006, 13:111.
21. Takahashi K. Pinpoint targeted immunosuppression in ABO-incompatible kidney transplantation-desensitization therapy without splenectomy. ABO-incompatible organ transplantation from Japan 2006, 73-87. Elsevier, Amsterdam. K. Takahashi (Ed.).
22. Sawada T., Fuchinoue S., Teraoka S. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusion, splenectomy, and double-filtration plasmapheresis. Transplantation 2002, 74:1207.
23. Tyden G., Kumlien G., Fehrman I. Successful ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Transplantation 2003, 27:1207.
24. Warren D.S., Zachary A.A., Montgomery R.A., et al. Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers. Am J Transplant 2004, 4:561.
25. Tyden G., Kumlien G., Genberg H., et al. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 2005, 5:145.
26. Norden G., Briggs D., Breimer M.E., et al. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment. Xenotransplantation 2006, 13:143.
27. Stegall M.D. Overcoming antibody barrier to transplantation: ABO-incompatible and positive cross-match kidney transplantation at Mayo Clinic-Rochester. International Congress Series 1292 ABO-incompatible organ transplantation from Japan 2006, 113-119. Elsevier, Amsterdam. K. Takahashi (Ed.).
28. Montgomery R.A., Locke J.E., King K.E., et al. ABO incompatible renal transplantation: a paradigm ready for broad implementation. Transplantation 2009, 87:1246.
29. Zhou W., Ohdan H., Tanaka Y., et al. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant. Transpl Immunol 2003, 12:9.
30. Irei T., Ohdan H., Zhou W., et al. The persistent elimination of B cells responding to blood group A carbohydrates by synthetic group A carbohydrates and B-1 cell differentiation blockade: novel concept in preventing antibody-mediated rejection in ABO-incompatible transplantation. Blood 2007, 110:4567.
31. Gleason R.E., Murray J.E. Report from kidney transplant registry: analysis of variables in the function of human kidney transplants. Transplantation 1967, 52:343.
32. Finne J., Krusius T., Rauvala H., Jarnefelt J. Molecular nature of the blood group ABH antigens of the human erythrocyte membrane. Rev Fr Transfus Immuno hematol 1980, 23:545.
33. Finne J. Identification of the blood-group ABH-active glycoprotein components of human erythrocyte membrane. Eur J Biochem 1980, 104:181.
34. Regele H., Bohmig G.A., Exner M., et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002, 13:2371.
35. Kanetsuna Y., Yamaguchi Y., Horita S., et al. C4d and/or immunoglobulins deposition in peritubular capillaries in perioperative graft biopsies in ABO-incompatible renal transplantation. Clin Transplant 2004, 18(Suppl. 11):13.
36. Hass M., Rahman M.H., Racusen L.C., et al. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings. Am J Transplant 2006, 6:1829.
37. Imai N., Nishi S., Takahashi K., et al. Immunohistochemical evidence of activated lectin pathway in kidney allografts with peritubular capillary C4d deposition. Nephrol Dial Transplant 2006, 21:2589.
38. Haga H., Egawa H., Monabe T., et al. Acute humoral rejection and C4d immuno staining in ABO blood type-incompatible liver transplantation. Liver Transpl 2006, 12:457.
39. Sakashita H., Haga H., Manabe T., et al. Significance of C4d staining in ABO-incompatible/compatible liver transplantation. Mod Pathol 2007, 20:576.
40. Takahashi K. ABO-incompatible organ transplantation. Curr Opin Organ Transplant 2007, 12:409.
41. Kobayashi T., Saito K. A series of surveys on assay for anti-A/B antibody by Japanese ABO-incompatible Transplantation Committee. Xenotransplantation 2006, 136.
42. Cardella C.J. Plasma exchange and renal transplantation. J Clin Apher 1985, 2:405.
43. Bannett A.D., Bensinger W.I., Raja R., et al. Immunoadsorption and renal transplant in two patients with a major ABO incompatibility. Transplantation 1987, 43:909.
44. Takahashi K., Agishi T., Oba S., et al. Extracorporeal plasma treatment for extending indication of kidney transplantation ABO-incompatible and preformed antibody-positive kidney transplantation. Therapeutic Plasmapheresis IX 1990, 61-63. ESAO Press, Cleveland.
45. Agishi K., Takahashi K., Ota K., et al. Japanese Biosynsorbe Research. Immunoadosorption of anti-A or anti-B antibody for successful kidney transplantation between ABO incompatible pairs and its limitation. ASAIO Trans 1991, 37:496.
46. Ota K., Takahashi K., Agishi T., et al. Japanese Biosynsorb ABO-incompatible kidney transplant group: multicenter trial of ABO-incompatible kidney transplantation. Transpl Int 1992, 5(Suppl.):40.
47. Nishi S., Hasegawa S., Takahashi K., et al. The safety measures for double filtration plasma apheresis (DFPP) before ABO incompatible kidney transplantation. International Congress Series 1292, ABO-incompatible organ transplantation from Japan 2006, 91-95. Elsevier, Amsterdam. K. Takahashi (Ed.).
48. Alexamdre G.P.J., Squifflet J.P., Bruyere M.D.E., et al. Splectomy as prerequisite for successful human ABO-incompatible renal transplantation. Transplant Proc 1985, 17:139.